346 related articles for article (PubMed ID: 15147210)
1. Two-site binding of beta-cyclodextrin to the Alzheimer Abeta(1-40) peptide measured with combined PFG-NMR diffusion and induced chemical shifts.
Danielsson J; Jarvet J; Damberg P; Gräslund A
Biochemistry; 2004 May; 43(20):6261-9. PubMed ID: 15147210
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process.
Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A
Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145
[TBL] [Abstract][Full Text] [Related]
3. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
4. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.
Danielsson J; Pierattelli R; Banci L; Gräslund A
FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176
[TBL] [Abstract][Full Text] [Related]
5. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
[TBL] [Abstract][Full Text] [Related]
6. Nicotine inhibits amyloid formation by the beta-peptide.
Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?
Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Sep; 37(37):12700-6. PubMed ID: 9737846
[TBL] [Abstract][Full Text] [Related]
8. Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display.
Wiesehan K; Buder K; Linke RP; Patt S; Stoldt M; Unger E; Schmitt B; Bucci E; Willbold D
Chembiochem; 2003 Aug; 4(8):748-53. PubMed ID: 12898626
[TBL] [Abstract][Full Text] [Related]
9. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
Milojevic J; Esposito V; Das R; Melacini G
J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
[TBL] [Abstract][Full Text] [Related]
11. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
12. Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.
Narayanan S; Reif B
Biochemistry; 2005 Feb; 44(5):1444-52. PubMed ID: 15683229
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease.
Mekmouche Y; Coppel Y; Hochgräfe K; Guilloreau L; Talmard C; Mazarguil H; Faller P
Chembiochem; 2005 Sep; 6(9):1663-71. PubMed ID: 16078307
[TBL] [Abstract][Full Text] [Related]
14. The metal loading ability of beta-amyloid N-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue.
Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
Inorg Chem; 2008 Oct; 47(20):9669-83. PubMed ID: 18808108
[TBL] [Abstract][Full Text] [Related]
15. alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35.
Narayanan S; Kamps B; Boelens WC; Reif B
FEBS Lett; 2006 Oct; 580(25):5941-6. PubMed ID: 17046756
[TBL] [Abstract][Full Text] [Related]
16. Zinc binding to Alzheimer's Abeta(1-16) peptide results in stable soluble complex.
Kozin SA; Zirah S; Rebuffat S; Hoa GH; Debey P
Biochem Biophys Res Commun; 2001 Jul; 285(4):959-64. PubMed ID: 11467845
[TBL] [Abstract][Full Text] [Related]
17. Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors.
Talmard C; Bouzan A; Faller P
Biochemistry; 2007 Nov; 46(47):13658-66. PubMed ID: 17983245
[TBL] [Abstract][Full Text] [Related]
18. NMR characterization of the interactions between lyso-GM1 aqueous micelles and amyloid beta.
Yagi-Utsumi M; Kameda T; Yamaguchi Y; Kato K
FEBS Lett; 2010 Feb; 584(4):831-6. PubMed ID: 20074569
[TBL] [Abstract][Full Text] [Related]
19. NMR and CD studies on the interaction of Alzheimer beta-amyloid peptide (12-28) with beta-cyclodextrin.
Qin XR; Abe H; Nakanishi H
Biochem Biophys Res Commun; 2002 Oct; 297(4):1011-15. PubMed ID: 12359256
[TBL] [Abstract][Full Text] [Related]
20. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
